Solid cancer risk after treatment of Hodgkin's disease

We pooled the data from seven studies of second cancer risk after treatment of Hodgkin's disease (HD) and estimated the relative risks (RR) of solid cancers (SC) for the following two treatment groups: (1) radiotherapy, with or without chemotherapy; and (2) chemotherapy alone. For all treatment groups combined, the RR of SC was 2.1 (95% confidence limits: 1.8 to 2.4). In the radiotherapy group, statistically significant RR were found for SC for all anatomic sites (RR: 2.2; 95% confidence limits: 1.9 to 2.6) and for SC of the bones and joints (RR: 20.0), soft tissues (RR: 18.3), non‐HD lymphomas (RR: 8.1), melanomas of the skin (RR: 6.7), buccal cavity and pharynx (RR: 4.1), nervous system (RR: 3.6), respiratory system (RR: 2.5), and digestive system (RR: 1.8). In the chemotherapy alone group, none of the RR differed significantly from unity, and the RR for SC of all sites was 1.1 (95% confidence limits: 0.5 to 1.9). The average duration of follow‐up for patients with chemotherapy was shorter than the duration of follow‐up for patients with radiotherapy. This may explain the general absence of elevated RR after chemotherapy.

[1]  H. Brincker,et al.  The incidence and characteristics of acute myeloid leukaemia arising in Hodgkin's disease. , 2009, Scandinavian journal of haematology.

[2]  R. Makuch,et al.  Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  B. Hankey,et al.  Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience. , 1984, Journal of the National Cancer Institute.

[4]  J. Boivin,et al.  Second primary cancers following treatment of Hodgkin's disease. , 1984, Journal of the National Cancer Institute.

[5]  E. Halperin,et al.  Sarcoma of bone and soft tissue following treatment of Hodgkin's disease , 1984, Cancer.

[6]  A. Bartolucci,et al.  Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease , 1983, Cancer.

[7]  M. Henry-Amar.  Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. , 1983, Journal of the National Cancer Institute.

[8]  A. Aisenberg.  Acute nonlymphocytic leukemia after treatment for Hodgkin's disease. , 1983, The American journal of medicine.

[9]  K. Franssila,et al.  Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non‐Hodgkin's lymphomas , 1983, Cancer.

[10]  E. Tawil,et al.  Second malignancy complicating Hodgkin's disease. , 1983, Journal of the Canadian Association of Radiologists.

[11]  S. Larsen,et al.  Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. , 1982, The New England journal of medicine.

[12]  C. Coleman,et al.  Secondary neoplasms in patients treated for cancer: etiology and perspective. , 1982, Radiation research.

[13]  S. Donaldson,et al.  Complications of treatment of Hodgkin's disease in children. , 1982, Cancer treatment reports.

[14]  T. Pajak,et al.  Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study. , 1982, Cancer treatment reports.

[15]  M. Gospodarowicz,et al.  Results of treating Hodgkin's disease without a policy of laparotomy staging. , 1982, Cancer treatment reports.

[16]  J. Bertino,et al.  Combined modality therapy for advanced Hodgkin's disease: long-term followup data. , 1982, Cancer treatment reports.

[17]  Coltman Ca,et al.  Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup. , 1982 .

[18]  A. Santoro,et al.  Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. , 1982, Blood.

[19]  E. Morra,et al.  Risk of leukemia in patients treated for Hodgkin's disease. , 1982, European journal of cancer & clinical oncology.

[20]  J. Boivin,et al.  Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease. , 1981, Journal of the National Cancer Institute.

[21]  M. Baccarani,et al.  Second malignancy in patients treated for Hodgkin's disease , 1980 .

[22]  D. Nelson,et al.  Second malignant neoplasms in patients treated for hodgkin's disease with radiotherapy or radiotherapy and chemotherapy , 1980, Cancer.

[23]  I. Mcdougall,et al.  Thyroid carcinoma after high‐dose external radiotherapy for Hodgkin's disease. Report of three cases , 1980, Cancer.

[24]  A. Santoro,et al.  Second malignancies in Hodgkin's disease: a complication of certain forms of treatment. , 1980, British medical journal.

[25]  S. Rosenberg,et al.  Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. , 1979, The New England journal of medicine.

[26]  L. Nisce,et al.  Complications of total nodal irradiation of Hodgkin's disease stages III and IV , 1978, Cancer.

[27]  B. Weinerman,et al.  Secondary malignant neoplasms in patients with Hodgkin's disease. , 1978, JAMA.

[28]  E. Glatstein,et al.  Hematologic neoplasia in patients treated for Hodgkin's disease. , 1977, The New England journal of medicine.

[29]  D. Schottenfeld,et al.  Multiple primary cancer risk after therapy for Hodgkin's disease , 1977, Cancer.

[30]  V. Devita,et al.  Risk of new cancers in patients with Hodgkin's disease , 1977, Cancer.

[31]  J. Whang‐Peng,et al.  SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION , 1975, The Lancet.

[32]  V. Devita,et al.  RECENTLY RECOGNIZED COMPLICATIONS OF CANCER CHEMOTHERAPY , 1974, Annals of the New York Academy of Sciences.

[33]  V. Devita,et al.  Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. , 1972, The New England journal of medicine.

[34]  Cornish Cb,et al.  MEDICAL TREATMENT OF OSTEOARTHRITIS. , 1965, Lancet.

[35]  A. Lindblad,et al.  Complications of Treatment , 1989 .

[36]  C. N. Coleman,et al.  Cutaneous malignant melanoma after Hodgkin's disease. , 1985, Annals of internal medicine.

[37]  E. Hall.  Radiation biology , 1985, Cancer.

[38]  M. Weil,et al.  [Acute leukemias and solid tumors in the course of Hodgkin disease]. , 1983, Bulletin du cancer.

[39]  K. Rothman,et al.  Epidemiologic Analysis with a Programmable Calculator , 1982 .

[40]  C. Coleman.  Leukemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease , 1982 .

[41]  C. Coltman,et al.  Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup. , 1982, Cancer treatment reports.

[42]  R. Connelly,et al.  Third national cancer survey: incidence data. , 1975, National Cancer Institute monograph.